Differences in Cardiovascular Risk Profile Between Electrocardiographic Hypertrophy Versus Strain in Asymptomatic Patients With Aortic Stenosis (from SEAS Data)

      Electrocardiograms are routinely obtained in clinical follow-up of patients with asymptomatic aortic stenosis (AS). The association with aortic valve, left ventricular (LV) response to long-term pressure load, and clinical covariates is unclear and the clinical value is thus uncertain. Data from clinical examination, electrocardiogram, and echocardiogram in 1,563 patients in the Simvastatin and Ezetimibe in Aortic Stenosis (SEAS) study were used. Electrocardiograms were Minnesota coded for arrhythmias and atrioventricular and intraventricular blocks; LV hypertrophy was assessed by Sokolow–Lyon voltage and Cornell voltage–duration criteria; and strain by T-wave inversion and ST-segment depression. Degree of AS severity was evaluated by echocardiography as peak aortic jet velocity and LV mass was indexed by body surface area. After adjustment for age, gender, LV mass index, heart rate, systolic and diastolic blood pressures, blood glucose, digoxin, antiarrhythmic drugs, drugs acting on the renin–angiotensin system, diuretics, β blockers and calcium receptor blockers; peak aortic jet velocity was significantly greater in patients with electrocardiographic strain (mean difference 0.13 m/s, p <0.001) and LV hypertrophy by Sokolow–Lyon voltage criteria (mean difference 0.12 m/s, p = 0.004). After similar adjustment, LV mass index was significantly greater in patients with electrocardiographic strain (mean difference 14.8 g/cm2, p <0.001) and LV hypertrophy by Sokolow–Lyon voltage criteria and Cornell voltage–duration criteria (mean differences 8.8 and 17.8 g/cm2, respectively, p <0.001 for the 2 comparisons). In multiple comparisons patients with electrocardiographic strain had increased peak aortic jet velocity, blood glucose, and uric acid, whereas patients with LV hypertrophy by Sokolow–Lyon voltage criteria were younger and patients with LV hypertrophy by Cornell voltage–duration criteria more often were women. In conclusion, electrocardiographic criteria for LV hypertrophy and strain are independently associated with peak aortic jet velocity and LV mass index. Moreover, clinical covariates differ significantly between patients with electrocardiographic strain and those with LV hypertrophy by Sokolow–Lyon voltage criteria and Cornell voltage–duration criteria.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to American Journal of Cardiology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Vahanian A.
        • Baumgartner H.
        • Bax J.
        • Butchart E.
        • Dion R.
        • Filippatos G.
        • Flachskampf F.
        • Hall R.
        • Iung B.
        • Kasprzak J.
        • Nataf P.
        • Tornos P.
        • Torracca L.
        • Wenink A.
        Guidelines on the management of valvular heart disease: the Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology.
        Eur Heart J. 2007; 28: 230-268
        • Lester S.J.
        • Heilbron B.
        • Gin K.
        • Dodek A.
        • Jue J.
        The natural history and rate of progression of aortic stenosis.
        Chest. 1998; 113: 1109-1114
        • Rossebø A.B.
        • Pedersen T.R.
        • Allen C.
        • Boman K.
        • Chambers J.
        • Egstrup K.
        • Gerdts E.
        • Gohlke-Bärwolf C.
        • Holme I.
        • Kesäniemi V.A.
        • Malbecq W.
        • Nienaber C.
        • Ray S.
        • Skjaerpe T.
        • Wachtell K.
        • Willenheimer R.
        Design and baseline characteristics of the Simvastatin and Ezetimibe in Aortic Stenosis (SEAS) study.
        Am J Cardiol. 2007; 99: 970-973
        • Rossebø A.B.
        • Pedersen T.R.
        • Boman K.
        • Brudi P.
        • Chambers J.B.
        • Egstrup K.
        • Gerdts E.
        • Gohlke-Bärwolf C.
        • Holme I.
        • Kesäniemi Y.A.
        • Malbecq W.
        • Nienaber C.A.
        • Ray S.
        • Skjaerpe T.
        • Wachtell K.
        • Willenheimer R.
        Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis.
        N Engl J Med. 2008; 359: 1343-1356
        • Prineas R.J.
        • Crowe R.S.
        • Blackburn H.
        The Minnesota Code Manual of Electrocardiographic Findings.
        in: John Wright, Bristol1982: 298
        • Rieck A.E.
        • Cramariuc D.
        • Staal E.M.
        • Rossebø A.B.
        • Wachtell K.
        • Gerdts E.
        Impact of hypertension on left ventricular structure in patients with asymptomatic aortic valve stenosis (a SEAS substudy).
        J Hypertens. 2010; 28: 377-383
        • Carabello B.A.
        What is new in the 2006 ACC/AHA guidelines on valvular heart disease?.
        Curr Cardiol Rep. 2008; 10: 85-90
        • Baumgartner H.
        • Hung J.
        • Bermejo J.
        • Chambers J.B.
        • Evangelista A.
        • Griffin B.P.
        • Iung B.
        • Otto C.M.
        • Pellikka P.A.
        • Quiñones M.
        Echocardiographic assessment of valve stenosis: EAE/ASE recommendations for clinical practice.
        Eur J Echocardiogr. 2009; 10: 1-25
        • Devereux R.B.
        • Alonso D.R.
        • Lutas E.M.
        • Gottlieb G.J.
        • Campo E.
        • Sachs I.
        • Reichek N.
        Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings.
        Am J Cardiol. 1986; 57: 450-458
        • Lang R.M.
        • Bierig M.
        • Devereux R.B.
        • Flachskampf F.A.
        • Foster E.
        • Pellikka P.A.
        • Picard M.H.
        • Roman M.J.
        • Seward J.
        • Shanewise J.S.
        • Solomon S.D.
        • Spencer K.T.
        • Sutton M.S.
        • Stewart W.J.
        Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology.
        J Am Soc Echocardiogr. 2005; 18: 1440-1463
        • Siegel R.J.
        • Roberts W.C.
        Electrocardiographic observations in severe aortic valve stenosis: correlative necropsy study to clinical, hemodynamic,, and ECG variables demonstrating relation of 12-lead QRS amplitude to peak systolic transaortic pressure gradient.
        Am Heart J. 1982; 103: 210-221
        • Wachtell K.
        • Bella J.N.
        • Liebson P.R.
        • Gerdts E.
        • Dahlöf B.
        • Aalto T.
        • Roman M.J.
        • Papademetriou V.
        • Ibsen H.
        • Rokkedal J.
        • Devereux R.B.
        Impact of different partition values on prevalences of left ventricular hypertrophy and concentric geometry in a large hypertensive population: the LIFE study.
        Hypertension. 2000; 35: 6-12
        • Friedman H.S.
        • Zaman Q.
        • Haft J.I.
        • Melendez S.
        Assessment of atrioventricular conduction in aortic valve disease.
        Br Heart J. 1978; 40: 911-917
        • Nair C.K.
        • Aronow W.S.
        • Stokke K.
        • Mohiuddin S.M.
        • Thomson W.
        • Sketch M.H.
        Cardiac conduction defects in patients older than 60 years with aortic stenosis with and without mitral anular calcium.
        Am J Cardiol. 1984; 53: 169-172
        • Selzer A.
        • Lombard J.T.
        Clinical findings in adult aortic stenosis—then and now.
        Eur Heart J. 1988; 9: 53-55